| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0015 | 1 |